Fritextsökning
Innehållstyper
-
Measure blood sugar without finger pricking
The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.
-
Annika Garnås, LAB
Why are you going to Scanlab+Biotech Forum?
-
Höjer bud på Actelion
Johnson & Johnson diskuterar förvärv av det schweiziska läkemedelsbolaget, och uppges nu ha höjt sitt bud.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Vill sälja USA-verksamheten
Enligt rykten diskuterar Meda en försäljning av sin amerikanska verksamhet.
-
New Nordic biotech company
The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
New nanotech professor to DTU
The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Transatlantic cooperation for healthier food
Danish and American scientists are going to work together to find ways to fight malnutrition and life style disease like obesity in the western world.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Pfizer väntas backa
Tidsfristen för Pfizer att lägga ett bud på Astrazeneca löper ut i dag och inget nytt bud verkar finnas på horisonten.
-
Finnish-Dutch engineering cooperation continues
The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.
-
EU grants project on toxicity of nanomaterials
A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Life science in Stockholm
Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.
-
"Imponerande kraftsamling gav vaccin"
Det rekordsnabba framtagandet av nya vaccin under pandemin visar vad läkemedelsindustrin – och mänskligheten – kan åstadkomma när pressen är tillräckligt stor.
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Storägare vill förhandla
Fondbolaget Blackrock och kapitalförvaltaren Grantham Mayo uppmanar Astrazenecas styrelse att hålla nya samtal med Pfizer.
-
Samuel Lagercrantz: Samarbete och samverkan är nyckeln till framgång
Trots att många frågor om covid-19 fortfarande är obesvarade har utvecklingen av läkemedel och vaccin gått otroligt snabbt, skriver Samuel Lagercrantz i en ledare.
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.
BREAKING